The number of women who've been handed a referral to a therapist when what they needed was a cardiologist is genuinely infuriating. Heart flutters, racing episodes, and that thudding-out-of-nowhere feeling are some of the most frightening things perimenopause throws at a person — and they deserve a real clinical conversation, not a pat on the hand.
Learn more about Rose →Estrogen receptors — specifically ERα and ERβ — are expressed in cardiac tissue, including the atria, where atrial fibrillation originates. Estrogen modulates the ion channels responsible for the action potential that keeps heart rhythm organised, particularly L-type calcium channels and potassium channels. As estrogen levels fall and fluctuate erratically during perimenopause, this regulation becomes unstable, creating conditions where abnormal electrical firing is more likely.
Estrogen has well-documented anti-inflammatory effects, and its withdrawal during perimenopause is associated with measurable increases in circulating inflammatory markers including CRP, IL-6, and TNF-alpha. Atrial inflammation is now recognised as a key driver of atrial fibrillation, contributing to atrial remodelling — structural and electrical changes that make the atria vulnerable to chaotic firing. This inflammatory shift begins years before the final menstrual period, meaning the risk window opens earlier than most women are told.
Estrogen helps maintain balance between the sympathetic and parasympathetic branches of the autonomic nervous system — the same system that governs heart rate variability. During perimenopause, this balance tips toward sympathetic dominance, which is associated with increased ectopic beats, reduced heart rate variability, and a lower threshold for arrhythmia. Hot flashes themselves represent acute sympathetic surges, and research has linked higher hot flash frequency to measurable autonomic dysfunction.
Poor sleep — driven by night sweats, anxiety, and the direct neurological effects of low estrogen — is independently associated with atrial fibrillation risk. Sleep deprivation elevates sympathetic tone, raises cortisol, and increases atrial ectopy, all of which lower the threshold for AFib episodes. In perimenopause, where disrupted sleep can persist for years, this isn't an occasional stressor on the heart — it becomes a chronic one.
Estrogen inhibits the fibrotic remodelling of cardiac tissue by suppressing pathways that lay down excess collagen in the atrial walls. When estrogen declines, atrial fibrosis can progress more rapidly — and fibrotic atrial tissue conducts electrical signals abnormally, creating the substrate on which AFib sustains itself. Studies in both animal models and postmenopausal women have found higher rates of atrial fibrosis compared to premenopausal controls, suggesting this process begins during the transition.
Estrogen supports vascular tone and arterial flexibility; its withdrawal is associated with increased arterial stiffness and blood pressure variability, both of which place mechanical stress on the atrial walls. Hypertension is the single largest modifiable risk factor for atrial fibrillation, and the perimenopausal years often mark the point where women's blood pressure begins to climb in ways that weren't present a decade earlier. The combination of structural atrial stress and the electrical instability described above creates a compounding risk profile.
Perimenopause is also a time when autoimmune thyroid conditions such as Hashimoto's thyroiditis become more prevalent, and even subclinical hyperthyroidism — TSH slightly suppressed, free T4 at the high end of normal — is a recognised independent trigger for atrial fibrillation. Because the symptoms of thyroid dysfunction (palpitations, anxiety, fatigue, weight changes, heat intolerance) overlap almost completely with perimenopausal symptoms, thyroid issues are frequently missed or attributed to hormones without investigation. Any woman experiencing palpitations during perimenopause warrants a full thyroid panel, not just a hormone check.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.